I

Isu Abxis Co Ltd
KOSDAQ:086890

Watchlist Manager
Isu Abxis Co Ltd
KOSDAQ:086890
Watchlist
Price: 5 100 KRW -4.32% Market Closed
Market Cap: 183.1B KRW
Have any thoughts about
Isu Abxis Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Isu Abxis Co Ltd stock under the Base Case scenario is 8 580.28 KRW. Compared to the current market price of 5 100 KRW, Isu Abxis Co Ltd is Undervalued by 41%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
8 580.28 KRW
Undervaluation 41%
Intrinsic Value
Price
I
Worst Case
Base Case
Best Case

Valuation Backtest
Isu Abxis Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Isu Abxis Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Isu Abxis Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Isu Abxis Co Ltd

Provide an overview of the primary business activities
of Isu Abxis Co Ltd.

What unique competitive advantages
does Isu Abxis Co Ltd hold over its rivals?

What risks and challenges
does Isu Abxis Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Isu Abxis Co Ltd.

Provide P/S
for Isu Abxis Co Ltd.

Provide P/E
for Isu Abxis Co Ltd.

Provide P/OCF
for Isu Abxis Co Ltd.

Provide P/FCFE
for Isu Abxis Co Ltd.

Provide P/B
for Isu Abxis Co Ltd.

Provide EV/S
for Isu Abxis Co Ltd.

Provide EV/GP
for Isu Abxis Co Ltd.

Provide EV/EBITDA
for Isu Abxis Co Ltd.

Provide EV/EBIT
for Isu Abxis Co Ltd.

Provide EV/OCF
for Isu Abxis Co Ltd.

Provide EV/FCFF
for Isu Abxis Co Ltd.

Provide EV/IC
for Isu Abxis Co Ltd.

Show me price targets
for Isu Abxis Co Ltd made by professional analysts.

What are the Revenue projections
for Isu Abxis Co Ltd?

How accurate were the past Revenue estimates
for Isu Abxis Co Ltd?

What are the Net Income projections
for Isu Abxis Co Ltd?

How accurate were the past Net Income estimates
for Isu Abxis Co Ltd?

What are the EPS projections
for Isu Abxis Co Ltd?

How accurate were the past EPS estimates
for Isu Abxis Co Ltd?

What are the EBIT projections
for Isu Abxis Co Ltd?

How accurate were the past EBIT estimates
for Isu Abxis Co Ltd?

Compare the revenue forecasts
for Isu Abxis Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Isu Abxis Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Isu Abxis Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Isu Abxis Co Ltd compared to its peers.

Compare the P/E ratios
of Isu Abxis Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Isu Abxis Co Ltd with its peers.

Analyze the financial leverage
of Isu Abxis Co Ltd compared to its main competitors.

Show all profitability ratios
for Isu Abxis Co Ltd.

Provide ROE
for Isu Abxis Co Ltd.

Provide ROA
for Isu Abxis Co Ltd.

Provide ROIC
for Isu Abxis Co Ltd.

Provide ROCE
for Isu Abxis Co Ltd.

Provide Gross Margin
for Isu Abxis Co Ltd.

Provide Operating Margin
for Isu Abxis Co Ltd.

Provide Net Margin
for Isu Abxis Co Ltd.

Provide FCF Margin
for Isu Abxis Co Ltd.

Show all solvency ratios
for Isu Abxis Co Ltd.

Provide D/E Ratio
for Isu Abxis Co Ltd.

Provide D/A Ratio
for Isu Abxis Co Ltd.

Provide Interest Coverage Ratio
for Isu Abxis Co Ltd.

Provide Altman Z-Score Ratio
for Isu Abxis Co Ltd.

Provide Quick Ratio
for Isu Abxis Co Ltd.

Provide Current Ratio
for Isu Abxis Co Ltd.

Provide Cash Ratio
for Isu Abxis Co Ltd.

What is the historical Revenue growth
over the last 5 years for Isu Abxis Co Ltd?

What is the historical Net Income growth
over the last 5 years for Isu Abxis Co Ltd?

What is the current Free Cash Flow
of Isu Abxis Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Isu Abxis Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Isu Abxis Co Ltd

Current Assets 87.3B
Cash & Short-Term Investments 31.3B
Receivables 27.2B
Other Current Assets 28.7B
Non-Current Assets 53.3B
Long-Term Investments 5.5B
PP&E 19.1B
Intangibles 27.9B
Other Non-Current Assets 749m
Current Liabilities 64.5B
Accounts Payable 4.2B
Accrued Liabilities 401.8m
Other Current Liabilities 59.9B
Non-Current Liabilities 5.7B
Long-Term Debt 345.6m
Other Non-Current Liabilities 5.4B
Efficiency

Earnings Waterfall
Isu Abxis Co Ltd

Revenue
62.1B KRW
Cost of Revenue
-17.2B KRW
Gross Profit
44.8B KRW
Operating Expenses
-30.4B KRW
Operating Income
14.4B KRW
Other Expenses
-20.4B KRW
Net Income
-6B KRW

Free Cash Flow Analysis
Isu Abxis Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Isu Abxis Co Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
ROE is Increasing
ROIC is Increasing
41/100
Profitability
Score

Isu Abxis Co Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Isu Abxis Co Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Negative Net Debt
Low D/E
Long-Term Solvency
73/100
Solvency
Score

Isu Abxis Co Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Isu Abxis Co Ltd

Wall Street analysts forecast Isu Abxis Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Isu Abxis Co Ltd is 9 792 KRW with a low forecast of 9 696 KRW and a high forecast of 10 080 KRW.

Lowest
Price Target
9 696 KRW
90% Upside
Average
Price Target
9 792 KRW
92% Upside
Highest
Price Target
10 080 KRW
98% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Isu Abxis Co Ltd?

Click here to dive deeper.

Dividends

Isu Abxis Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Isu Abxis Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Isu Abxis Co Ltd

Country

Korea

Industry

Biotechnology

Market Cap

190.1B KRW

Dividend Yield

0%

Description

ISU Abxis Co., Ltd. engages in the provision of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do and currently employs 143 full-time employees. The company went IPO on 2009-02-03. The firm operates its business under two divisions: antibody therapeutics business division and diagnostic business division. Its antibody therapeutics business division engages in the development of Cloticab, which is a monoclonal therapeutic antibody for thrombus. Its diagnostic business division engages in the provision of genetic testing services and chemotherapy response assay services for cancer examination.

Contact

GYEONGGI-DO
Seongnam
5F, 4F, C Dong, Global R&D Center, 22, Daewangpangyo-ro 712beon-gil, Bundang-gu
+82316964700
www.abxis.com

IPO

2009-02-03

Employees

143

Officers

Chief Exec. Officer
Sang-Ho Park Ph.D.
Exec.
Jae-Heung Lee

See Also

Discover More
What is the Intrinsic Value of one Isu Abxis Co Ltd stock?

The intrinsic value of one Isu Abxis Co Ltd stock under the Base Case scenario is 8 580.28 KRW.

Is Isu Abxis Co Ltd stock undervalued or overvalued?

Compared to the current market price of 5 100 KRW, Isu Abxis Co Ltd is Undervalued by 41%.

Back to Top